Updated results on a new approach to treating advanced ER-positive/HER2-negative breast cancer

A UCLA Jonsson Comprehensive Cancer Center researcher and collaborators in a multicenter study will present updated results and plans for further research on a new approach to treating advanced ER-positive/HER2-negative breast cancer.

Related Keywords

Charlotte ,North Carolina ,United States ,Norwalk Hospital ,Connecticut ,Tennessee ,Missouri ,Stanford University ,California ,New Haven ,San Antonio ,Texas ,Washington University ,Michigan ,San Francisco ,Sara Hurvitz ,Rita Nanda ,Richard Gedrich ,Rinath Jeselsohn ,Melinda Telli ,Emily Henderson ,Haolan Lu ,Pamela Munster ,George Zahrah ,Janaki Parameswaran ,Jesus Anampa Mesias ,Natasha Hunter ,Anne Schott ,Phyo Han ,Cynthia Ma ,Cecile Mather ,University Of California ,Stanford University School Of Medicine ,Jonsson Comprehensive Cancer Center ,Levine Cancer Institute ,Seattle Cancer Care Alliance ,Sarah Cannon Research Institute Tennessee Oncology ,University Of Chicago Medicine ,Arvinas Operations Inc ,Albert Einstein College Of Medicine ,Moffitt Cancer Center ,Apollo Medical Communications ,Farber Cancer Institute ,Arvinas Estrogen Receptor Inc ,Clinical Research Unit ,University Of Michigan Health ,Comprehensive Cancer Center ,San Antonio Breast Cancer ,Arvinas Estrogen Receptor ,Arvinas Operations ,Michigan Health ,Erika Hamilton ,Sarah Cannon Research ,Tennessee Oncology ,Chicago Medicine ,Antoinette Tan ,Stanford University School ,Albert Einstein College ,Breast Cancer ,Dancer ,Ndocrine ,Estrogen ,Hormonal Therapy ,Medicine ,Eceptor ,Research ,